Inactive Instrument

Vivimed Labs Ltd Stock NSE India S.E.

Equities

INE526G01013

Pharmaceuticals

End-of-day quote NSE India S.E.
- INR - Intraday chart for Vivimed Labs Ltd

Financials

Sales 2022 2.39B 28.59M 39.17M Sales 2023 1.88B 22.54M 30.88M Capitalization 547M 6.56M 8.99M
Net income 2022 -677M -8.11M -11.12M Net income 2023 -3.28B -39.37M -53.94M EV / Sales 2022 1.98 x
Net Debt 2022 3.52B 42.15M 57.75M Net Debt 2023 3.77B 45.22M 61.95M EV / Sales 2023 2.3 x
P/E ratio 2022
-1.78 x
P/E ratio 2023
-0.17 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 74.35%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 62 89-11-08
Compliance Officer - -
Corporate Officer/Principal - -
Members of the board TitleAgeSince
Chief Executive Officer 62 89-11-08
Director/Board Member 55 08-01-22
Director/Board Member 76 89-11-08
More insiders
Vivimed Labs Limited is an India-based company, which is primarily engaged in the business of active pharmaceuticals ingredients, contract development and manufacturing operations finished dosage formulation, specialty chemicals and retail branded formulation manufacturing. The Company has two segments: Speciality Chemicals Business and Pharma Business. It supplies niche molecules and formulations for healthcare, pharmaceuticals and specialty chemical consumers in nearly 50 countries. Its active ingredients are used in home and personal care products, such as hair, skin, oral care and anti-microbial preservatives. It also offers industrial care products, such as photo chromic dyes and imaging chemicals. Its presence in active pharmaceutical ingredients, finished dosage formulation (FDF) and retail branded formulation manufacturing, caters to the inner health of people. Within the FDF business, it provides contract manufacturing services and the manufacture of branded formulations.
More about the company